XML 113 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Recognized compensation expenses The Company recognized compensation expense related to the Company Plans for the fiscal years ended December 31, 2012, January 1, 2012 and January 2, 2011 as follows (in thousands):   2012 2011 2010Stock option plan expense $2,539 $2,681 $1,378Restricted stock expense $4,449 $3,432 $3,261
Summary of the activity of stock option awards
A summary of the activity of the Company’s stock options plans is presented below:
 
 
 
Shares
 
Wtd. Avg.
Exercise
Price
 
Wtd. Avg.
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
 
 
(In thousands)
 
 
 
 
 
(In thousands)
Options outstanding at January 1, 2012 [1]
 
1,601

 
$
19.44

 
6.73
 
$
2,778

Granted [2]
 
96

 
22.30

 
 
 
 
Exercised [1]
 
(593
)
 
15.65

 
 
 
 
Forfeited/Canceled [1]
 
(73
)
 
22.93

 
 
 
 
Incremental shares granted due to anti-dilution provision existing in the compensation plans
 
167

 

 
 
 
 
Options outstanding at December 31, 2012 [2]
 
1,198

 
$
18.92

 
6.85
 
$
11,090

Options vested and expected to vest at December 31, 2012 [2]
 
1,153

 
$
18.90

 
6.79
 
$
10,785

Options exercisable at December 31, 2012 [2]
 
722

 
$
17.51

 
5.95
 
$
7,694

[1] Weighted Average Exercise Price reflects initial exercise price and has not been adjusted in the table above for the Adjustment Factor in connection with the Special Dividend.
[2] Weighted Average Exercise Price reflects the Adjustment Factor in connection with the Special Dividend.
The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of fiscal year 2012 and the exercise price, times the number of shares that are “in the money”) that would have been received by the option holders had all option holders exercised their options on December 31, 2012. This amount changes based on the fair value of the Company’s stock.
The following table summarizes information relative to stock option activity during the Company’s fiscal years ended December 31, 2012January 1, 2012 and January 2, 2011 (in thousands):
 
 
 
2012
 
2011
 
2010
Intrinsic value of options exercised
 
$
7,051

 
$
4,718

 
$
21,095

Fair value of shares vested
 
$
2,062

 
$
2,358

 
$
2,054

Exercise prices and related information of stock option outstanding
The following table summarizes information about the exercise prices and related information of stock options outstanding under the Company Plans at December 31, 2012:
 
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number
Outstanding
 
Wtd. Avg.
Remaining
Contractual
Life
 
Wtd.  Avg.
Exercise
Price
 
Number
Exercisable
 
Wtd. Avg.
Remaining
Contractual
Life
 
Wtd.  Avg.
Exercise
Price
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
3.17 – 5.26
 
29

 
1.0
 
$
4.55

 
30

 
1.0
 
$
4.55

6.66 – 13.72
 
46

 
2.42
 
9.15

 
45

 
2.33
 
9.03

14.44 – 22.26
 
1,021

 
6.97
 
19.44

 
629

 
6.37
 
18.59

22.30 – 24.61
 
102

 
9.35
 
22.32

 
18

 
8.10
 
22.36

Total
 
1,198

 
6.8
 
$
18.92

 
722

 
5.95
 
$
17.51

Status of non - vested stock options
The following table summarizes the status of non-vested stock options as of January 1, 2012 and changes during the fiscal year ending December 31, 2012:
 
 
 
Number of Shares
 
Wtd. Avg. Grant
Date Fair Value
 
 
(In thousands)
 
 
Options non-vested at January 1, 2012
 
605

 
$
8.99

Granted
 
96

 
6.81

Vested
 
(184
)
 
8.32

Forfeited
 
(41
)
 
8.96

Options non-vested at December 31, 2012
 
476

 
$
8.89

Summary of the activity of restricted stock
A summary of the activity of restricted stock is as follows:
 
 
Shares
 
Wtd. Avg.
Grant  date
Fair value
 
 
(In thousands)
 
 
Restricted stock outstanding at January 1, 2012
 
442

 
$
23.32

Granted
 
315

 
18.40

Vested
 
(145
)
 
23.28

Forfeited/Canceled
 
(28
)
 
22.79

Restricted stock outstanding at December 31, 2012
 
584

 
$
20.98